Literature DB >> 22552091

Translational medicine: Double protection for weakened bones.

Mone Zaidi, Jameel Iqbal.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22552091     DOI： 10.1038/485047a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  8 in total

Review 1.  Skeletal remodeling in health and disease.

Authors:  Mone Zaidi
Journal:  Nat Med       Date:  2007-07       Impact factor: 53.440

2.  Neuropilin is a receptor for the axonal chemorepellent Semaphorin III.

Authors:  Z He; M Tessier-Lavigne
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

3.  Osteoprotection by semaphorin 3A.

Authors:  Mikihito Hayashi; Tomoki Nakashima; Masahiko Taniguchi; Tatsuhiko Kodama; Atsushi Kumanogoh; Hiroshi Takayanagi
Journal:  Nature       Date:  2012-05-03       Impact factor: 49.962

Review 4.  Class 3 semaphorin signaling: the end of a dogma.

Authors:  Vincent Potiron; Joëlle Roche
Journal:  Sci STKE       Date:  2005-05-24

Review 5.  Semaphorins and neuropilins: new players in the neuroendocrine control of the intrathymic T-cell migration in humans.

Authors:  Daniella Arêas Mendes-da-Cruz; Leandra Linhares-Lacerda; Salete Smaniotto; Mireille Dardenne; Wilson Savino
Journal:  Exp Physiol       Date:  2012-02-10       Impact factor: 2.969

6.  Regulation of semaphorin III/collapsin-1 gene expression during peripheral nerve regeneration.

Authors:  R J Pasterkamp; R J Giger; J Verhaagen
Journal:  Exp Neurol       Date:  1998-10       Impact factor: 5.330

7.  Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models.

Authors:  Federica Maione; Fabiola Molla; Claudia Meda; Roberto Latini; Lorena Zentilin; Mauro Giacca; Giorgio Seano; Guido Serini; Federico Bussolino; Enrico Giraudo
Journal:  J Clin Invest       Date:  2009-10-05       Impact factor: 14.808

8.  Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model.

Authors:  Goutam Chakraborty; Santosh Kumar; Rosalin Mishra; Tushar V Patil; Gopal C Kundu
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240
  8 in total
  7 in total

Review 1.  Regulation of Skeletal Homeostasis.

Authors:  Mone Zaidi; Tony Yuen; Li Sun; Clifford J Rosen
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

Review 2.  Bone metabolism in 2012: Novel osteoporosis targets.

Authors:  Claes Ohlsson
Journal:  Nat Rev Endocrinol       Date:  2013-01-08       Impact factor: 43.330

3.  Opening windows for bone remodeling through a SLIT.

Authors:  Jameel Iqbal; Tony Yuen; Se-Min Kim; Mone Zaidi
Journal:  J Clin Invest       Date:  2018-03-05       Impact factor: 14.808

4.  The role of PDGF-BB in the bone-vascular relationship during aging.

Authors:  Mone Zaidi; Daria Lizneva; Tony Yuen
Journal:  J Clin Invest       Date:  2021-10-15       Impact factor: 19.456

5.  Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis.

Authors:  Ling-Ling Zhu; Harry Blair; Jay Cao; Tony Yuen; Rauf Latif; Lida Guo; Irina L Tourkova; Jianhua Li; Terry F Davies; Li Sun; Zhuan Bian; Clifford Rosen; Alberta Zallone; Maria I New; Mone Zaidi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

6.  Sanguinarine protects against ovariectomy‑induced osteoporosis in mice.

Authors:  Yan Ma; Junjie Chu; Jianjun Ma; Lei Ning; Ke Zhou; Xiangqian Fang
Journal:  Mol Med Rep       Date:  2017-05-11       Impact factor: 2.952

7.  Combined Red Clover isoflavones and probiotics potently reduce menopausal vasomotor symptoms.

Authors:  Max Norman Tandrup Lambert; Anne Cathrine Thorup; Esben Søvsø Szoscka Hansen; Per Bendix Jeppesen
Journal:  PLoS One       Date:  2017-06-07       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.